Valuation: CROSSJECT

Market Cap 8.6Cr 10Cr 8.07Cr 7.37Cr 14Cr 956.71Cr 14Cr 96Cr 37Cr 482.92Cr 38Cr 37Cr 1.6TCr P/E 2026 *
3.85x
P/E 2027 * 3.04x
Enterprise Value 6.81Cr 7.94Cr 6.39Cr 5.84Cr 11Cr 757.63Cr 11Cr 76Cr 29Cr 382.43Cr 30Cr 29Cr 1.26TCr EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.92x
Free-Float
91.83%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+5.66%+19.59%-21.70%-32.63% 13Cr
+6.76%+8.82%+0.38%-60.50% 9.4Cr
-2.48%+2.15%+98.90%+54.10% 9.03Cr
+4.93%+27.35%+65.85%-11.83% 6.41Cr
Average +3.72%+10.58%+35.86%-12.72% 9.36Cr
Weighted average by Cap. +3.85%+10.26%+27.91%-15.15%

Financials

2026 *2027 *
Net sales 6.08Cr 7.09Cr 5.7Cr 5.21Cr 9.83Cr 676.2Cr 9.87Cr 68Cr 26Cr 341.33Cr 27Cr 26Cr 1.13TCr 4.23Cr 4.93Cr 3.97Cr 3.63Cr 6.84Cr 470.45Cr 6.86Cr 47Cr 18Cr 237.47Cr 19Cr 18Cr 785Cr
Net income 2.83Cr 3.3Cr 2.65Cr 2.43Cr 4.58Cr 314.75Cr 4.59Cr 31Cr 12Cr 158.88Cr 12Cr 12Cr 525.19Cr 77.5L 90.32L 72.7L 66.43L 1.25Cr 86Cr 1.26Cr 8.6Cr 3.34Cr 44Cr 3.39Cr 3.32Cr 143.82Cr
Net Debt -1.79Cr -2.09Cr -1.68Cr -1.53Cr -2.89Cr -199.08Cr -2.9Cr -20Cr -7.71Cr -100.49Cr -7.83Cr -7.66Cr -332.19Cr -4.7Cr -5.48Cr -4.41Cr -4.03Cr -7.6Cr -522.72Cr -7.63Cr -52Cr -20Cr -263.86Cr -21Cr -20Cr -872.23Cr
Logo CROSSJECT
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-